Eric Ma

Eric Ma, Ph.D., is a seasoned researcher with a robust background in immunology and metabolism. Currently serving as a Senior Research Investigator at Biohaven since March 2024, Eric's previous roles include Scientist II at Clade Therapeutics and Rheos Medicines, as well as Staff Scientist and Postdoctoral Research Fellow at the Van Andel Institute. Eric completed a Ph.D. in Immunology and Metabolism at McGill University, where studies were conducted from September 2013 to March 2019, after obtaining a Bachelor of Science with Honors in Biochemistry from the same institution, graduating in 2013. Additionally, Eric gained experience as a Cell Metabolism Intern at Agios Pharmaceuticals in the summer of 2018.